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During the past decades liver transplantation has become a routine mode of therapy
for patients suffering from end stage liver disease. To bridge the time span between
donor hepatectomy and transplantation, livers are nowadays routinely preserved by
static cold storage (CS) i.e. the liver is flushed in situ with a cold preservation solution
and are, following hepatectomy, stored in a preservation solution on melting ice. The
decrease in temperature results in a decrease of liver metabolism. At this lowered
metabolic rate, the need for nutrients diminishes and production of waste products
decreases substantially. Storage at 0-4 °C results in 90-95% reduction of cellular
metabolism1, and throughout the years, 0-4 °C has shown to be an adequate
temperature for static CS. In the 1980s Belzer and his co-workers optimised the CS
technique with the development of the University of Wisconsin-cold storage solution
(UW-CSS)2,3. UW-CSS allows preservation of donor livers for 12 to 18 hours in the
clinical setting and even storage beyond 48 hours in laboratory experiments compared
to approximately six hours in EuroCollins4-7. Despite the success of UW-CSS and the
introduction of improved and more specific immunosupressiva in addition to a better
understanding and treatment of complications, the limits of static CS using the concept
of UW-CSS appear to be reached. 
To date, the majority of donor livers used for transplantation originate from brain
dead donors. Livers from marginal or non-heart-beating donors are presumed to have a
poorer quality and are rarely used for transplantation because of an expected decreased
organ viability and associated technical complications. To overcome the present
shortage of donors by expansion of the existing donor pool and possibly lengthening of
the storage time machine perfusion as a dynamic preservation method is revisited. 
Already in the 1960s, Belzer et al. started experiments with hypothermic machine
perfusion preservation (HMP) by studying continuous perfusion of kidneys8. His efforts,
along with others, resulted in improved clinical results using continuous perfused
kidney preservation in comparison to CS. With HMP, the use of non-heart-beating and
so-called marginal kidney donors is now feasible9-14. In the laboratory even five to
seven days successful preservation of canine kidneys can be achieved15,16. Because of
these successes and the potential to increase the donor pool and prolong storage times,
continuous preservation of the liver has gained renewed interest. On the basis of the
success of HMP of the kidney, continuous machine perfusion of the liver could
contribute to better preservation of normal heart-beating donor livers, facilitate the use
of marginal donor livers and could nowadays also allow liver transplantation from non-
heart-beating donors.
In the late 1960s Belzer et al, Slapak et al and Brettschneider et al experimented with
continuous hypothermic machine perfusion of the liver in the experimental setting with
results comparable or even better than livers preserved with static CS17-19. In 1986
D’Alessandro et al and later Pienaar et al managed to transplant good quality canine
livers after 72 hours preservation in a HMP dog model10, 20. 
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Despite successful experiences with continuous perfusion of kidneys and the results
obtained by Pienaar with liver preservation, HMP did not became a standard procedure
in every day practise. Moreover, until today, there is no commercially available liver
perfusion machine to improve organ viability and seriously challenge the limits of liver
preservation by optimising perfusion and transportation during cold storage, as it has
been done with machine preservation of kidneys in dedicated centres. 
This review describes the rationale to the design of a portable liver HMP system and
includes a list of relevant features. We will discuss relevant design criteria concerning:
preservation solution, characteristics of perfusion dynamics and necessity of
oxygenation. Furthermore, a new HMP design is presented in which the discussed
features are incorporated.
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Hypothermic organ preservation
Despite many achievements in preservation, hypothermia is, until today, the key
principle to prevent viability loss of donor livers. Hypothermia decreases metabolism
and prevents catabolic processes, however, hypothermia invokes cellular injury as well.
To rapidly decrease the core temperature of the donor organ, a cold substitute for warm
blood should be infused, keeping protection for cold induced injury in mind. Solutions
used for hypothermic organ preservation should, thus, wash-out donor blood, decrease
the organ's core temperature, contain protective components to prevent cold induced
cellular injury, maintain osmotic balance between interstitial and vascular spaces and
supply the hepatic cells with oxygen21.
In the early days of liver HMP research, perfusion was established using autologous
diluted blood or plasma-based solutions17,19,22,23. Since preservation with these
cellular solutions, however, was not very successful, a shift towards a-cellular perfusion
solutions has occurred. Slapak initially perfused livers with saline in the late 1960s, and
later perfusion with cold Krebs-Henseleit bicarbonate and lactated-Ringer’s solution was
reported. The UW-Machine Perfusion solution (UW-MP), developed by Belzer and
Southard, is an a-cellular solution used by most centres for HMP20,24-28. It satisfies the
physiological and biochemical requirements for a HMP solution including gluconate to
prevent hypothermia induced cell swelling, phosphate to prevent intracellular acidosis,
glutathione and allopurinol to inhibit oxygen free radical formation, adenosine to
stimulate ATP synthesis and finally hydroxyethyl starch to keep the vasculature open
and prevent edema. The UW-MP solution, used for HMP, differs from the cold-storage
solution UW-CSS. In UW-MP gluconate is included as an impermeant versus
lactiobionate in UW-CSS. Using the UW-MP solution, Pienaar et al found a 90% survival
after 72 h HMP of dog livers. Successful experiments were also described by Boudjema
et al, Kim et al and Yamamoto et al20,24,26,28. However, despite the success of the UW-
MP solution, the same solution has negative side effects as well. The inclusion of high-
molecular weight hydroxyethyl starch, for example, increases the viscosity of the UW-
solutions, compared to blood or solutions without a colloid (e.g. lactated-Ringer’s or
Krebs-Henseleit bicarbonate). The increased viscosity of the UW-solutions has been
blamed for a sub-optimal wash-out of blood cells during the initial flush of the donor
organ29-31. Pirenne et al even stated that prevention of biliary complications after
transplantation depends on the viscosity of the preservation solution used32. Recently,
we found that not so much the viscosity but instead an increased red blood cell
aggregation during initial wash-out of blood due to the high-molecular weight
hydroxyethyl starch appears to be the key factor33. To eliminate the negative effects of
the increased viscosity and/or the increased red blood cell aggregation, we recommend
to perform the initial wash-out with a low-viscous aggregation-preventing solution33.
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This can be done by flushing with e.g. lactated-Ringer’s20,25,28,34 or EuroCollins
solution35-38, or with UW without hydroxyethyl starch (HES) as well29,39. Subsequently,
organs should be perfused with the preservation solution according to the method of
preservation.
Recently, Celsior, a new CS preservation solution, has been developed along the same
specifications as the UW-CSS, but with slight changes as the omission of hydroxyethyl
starch. Compagnon et al used for their continuous perfusion experiments high-molecular
weight HES for osmotic balance between tissue and Celsior-solution. With the use of
Celsior-HES they introduced negative effects of HES as HES increases viscosity and red
blood cell aggregation during initial wash-out. Compagnon still found satisfying results,
showing better viability parameters in HMP compared to cold storage. 
Summarizing, an effective wash-out of blood can be achieved by pre-flushing the
liver with a low-viscous aggregation-preventing solution. To restore osmotic balances,
hypothermic machine preservation should be continued using UW-MP or a UW-look-a-
like solution which contains a colloid, in order to prevent edema formation and maintain
the protective effects for cold-induced cellular injury. 
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Perfusion dynamics
Theoretical considerations of hypothermic machine perfusion
The liver is supplied with blood from both the portal vein and the hepatic artery. The
portal vein, with a mean blood pressure of 12 mmHg, supplies the liver cells with blood
coming from the splanchnic area and intestine, and contributes to approximately 2/3 of
total liver perfusion. The hepatic artery, with a pulsatile blood pressure of 120/80 mmHg
supplies blood to the liver sinusoids, vessel walls, as well as to the biliary tree. It is an
important factor in maintaining vessel structure and integrity of bile ducts. The blood
supply of both afferent blood vessels joins in the sinusoids and leaves the liver through
the hepatic veins into the inferior caval vein. 
When HMP of the liver intends to mimic the physiological circulation, two aspects
have to be taken into account. First, the temperature effect: using hypothermia alters
vascular compliance and second, the solution effect: using different composition and
properties of the preservation solution alters rheological conditions. 
The temperature effect. Lowering the temperature from 37 °C to 4 °C results in
vasoconstriction of the hepatic vasculature and an increase in flow resistance.
Hypothermia decreases the Ca++-ATPase activity to virtually zero, inducing
vasoconstriction of the vessels41. As a consequence, the decreased diameter of the
vessels causes an increased resistance to flow. Furthermore, if we assume Poiseuille's
law, the resistance even increases with the fourth power of the diameter. Fortunately, it
is known from hypothermic kidney perfusion that this vasoconstriction subsides in most
cases in the first 30 minutes of perfusion42. In addition, low temperatures also alter the
physiological and biochemical characteristics of cells with loss of transmembrane ion
gradients and membrane barrier functions43. As a result, endothelial cells, that play a
substantial role in preservation injury, become more prone to damage43. Due to the
increased sensitivity of endothelial cells to injury, detrimental factors like very high,
very low and rapidly fluctuating degrees of shear stress should be avoided during organ
preservation44. 
The solution effect. Since the liver is preserved at cold temperatures, liver perfusion
also uses a different perfusion medium than in real life. Instead of blood, the liver is
perfused with an a-cellular medium. The viscosity of blood at 37 °C is approximately
4·10-3 Pa·s for high shear rates45. This viscosity increases for lower shear rates as the
influence of blood cells becomes more apparent compared to plasma (non-Newtonian).
The viscosity of blood decreases in small capillaries, as the ratio blood cells/plasma
changes, in favour of plasma (Fahreus-Lindqvist effect). In an a-cellular fluid the non-
linear viscosity is absent, and the viscosity will approach viscosity values of pure water
at 4 °C, being approximately 2·10-3 Pa·s. In the UW-solutions, however, a colloid is
present and it has been shown that this colloid causes a non-linear component in the
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viscosity33. It has also been demonstrated that the viscosity of UW-solutions at 4 °C is
11·10-3 Pa·s, which renders this solution three times more viscous than blood. From
Poiseuille’s law, , with L as the length of a cylindrical tube and r the
radius, it can be concluded that pressure difference (P) and resulting flow (Q) are
proportional to the dynamic viscosity (η). In other words, if the same pressure is used
with another fluid with a viscosity that is three times as high, the resulting flow is three
times as low. This should be taken into account when pressures or flow in hypothermic
liver perfusion are defined.
Review of HMP techniques
In the pioneering years of liver HMP the idea was to mimic the physiological situation
as good as possible. Both the hepatic artery and the portal vein were perfused by
Brettschneider et al from Starzl’s group in a continuous manner, but Slapak et al and
Belzer et al used pulsatile perfusion through the hepatic artery and simultaneously non-
pulsatile perfusion via the portal vein19,46,17. With these methods, successful HMP has
been obtained, reaching 24 hours preservation. In the following years, physiology-
mimicking pumping configurations were used by other research groups22,47. In the mid-
eighties single vessel perfusion became the accepted method. Many authors limited their
HMP experiments to just portal venous perfusion in a continuous manner24,26,28,29,40-50
and found good results of HMP up to 72 hours, which in fact is superior to traditional
CS. The most successful liver preservation experiments were performed by Pienaar et al
in the lab from Belzer and Southard at the University of Wisconsin, who used pulsatile
perfusion of the portal vein only20. They found seven out of eight dogs surviving for
seven or more days after transplantation of a liver that was preserved for 72 hours in
UW-MP. This is a remarkable result, taking into account that only the portal vein was
perfused. Yamamoto et al also achieved successful HMP of porcine livers for 72 hours,
however, they used continuous portal venous perfusion28. A comparison between the
two experiments is difficult, because Yamamoto did not judge the result in a
transplantation model, as Pienaar did, but assessed liver viability in an isolated perfused
liver (IPL) model. Over the years, the IPL-model has been validated as a representative
reperfusion model, despite the absence of blood cells and allorecognition in the IPL-
model. Thus, it appears that in liver preservation under hypothermic conditions both
pulsatile and continuous perfusion can be used through the portal vein.
Recently, Compagnon et al compared different routes of perfusion in a rat liver
model40. A comparison of single vessel perfusion between portal venous and arterial
perfusion is described and viability of the rat liver was tested in an IPL-model. They
concluded that portal venous perfusion proved to be superior over static CS. Single
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The perfusion characteristics of some landmark experiments that were performed
throughout the years are listed in table 1. The magnitude of portal perfusion pressure
used varies from 2 mmHg to 25 mmHg, and flow varies from 0.14 ml/min/g-liver to 4.8
ml/min/g-liver. In all experiments, the authors, however, report superior results of HMP
compared to CS. Thus, the portal vein is apparently rather insensitive to pressure and
flow magnitude. Unfortunately, perfusion characteristics in these studies are often
poorly defined. For better comparison of these experiments using continuous perfusion,
the applied perfusion pressure and resulting flow should be described. Pulsatile
perfusion is best characterised using the mean and amplitude of pressure in addition to
pulse frequency. The hydraulic power, which is defined as the product of instantaneous
pressure and instantaneous flow, is also a good characterisation of pulsatile perfusion51.
Resulting flows should also mention mean and amplitude. The majority of experiments
use lower than physiologic pressures, probably on the basis of the concept that
endothelial cells are more fragile under hypothermic conditions. Due to lack of data
concerning pulse frequency and amplitude arterial perfusion of the liver has never been
described satisfactory. In this respect, data from kidney HMP can be helpful to assess
the arterial perfusion of the liver. In the past, kidney HMP has been shown as a very
successful method of pulsatile preservation using a pressure of 60/40 mmHg and pulse
rate of 60 BPM, as described by several authors (Table 1). 
Table 1: Experimental perfusion characteristics used in liver HMP (=: continuous, ≈: pulsatile, if
blank only portal perfusion was used).
Reference Species Portal vein Hepatic artery Temperature
Slapak et al18 Canine 12 mmHg (=) 76/23 mmHg (≈) 11 °C
Brettschneider et al19 Canine 4.8 ml/min/g (=) 1.2 ml/min/g (=) 4 °C
Belzer et al17 Porcine 5-8 mmHg (=) 60/40 mmHg (≈) 8-10 °C
Gellert et al22 Porcine 2 mmHg (=) 80/40 mmHg 10 °C 
0.5 ml/min/g (≈)0.125 ml/min/g
Pienaar et al20 Canine 16-18 mmHg (30 BMP ≈) 5 °C
Boudjema et al24 Rodent (rabbit) 15-25 mmHg (=) 5 °C
Yamamoto et al28 Porcine 0.5-0.6 ml/min/g (=) 7 °C
Rossaro et al66 Rodent (rat) 0.5 ml/min/g (=) 6-10 °C
Kim et al26 Rodent (rat) 11 mmHg (=)0.5 ml/min/g 4 °C
Southard et al27 Rodent (rat) 0.14 ml/min/g (=) 4 °C
Compagnon et al40 Rodent (rat) 0.4 ml/min/g (=) 0.1 ml/min/g (=) 4 °C
Summarizing, good results with HMP of the liver have been obtained by perfusion of
the portal vein alone, while additional advantages, including better preservation of the
sinusoids and biliary tree, could be gained by including perfusion of the hepatic
artery20,28,32. In a dual perfusion system of both portal vein and hepatic artery, portal
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perfusion could be performed using either pulsatile or non-pulstatile perfusion at a
pressure ranging from 2-25 mmHg and arterial perfusion preferably in a pulsatile manner
at 60/40 mmHg and a pulse rate of 60 BPM.
The role of oxygen in hypothermic preservation
One of the key factors in organ preservation is hypothermia. Hypothermia decreases
the rate at which metabolism occurs. The decrease of reaction rates is represented by
van ’t Hoff’s principle and can be expressed by:
with Q10 being van ’t Hoff’s coefficient  for a 10 °C temperature change and k1 and k2
the reaction rates at temperatures t1 and t2 respectively. In metabolic pathways, van ’t
Hoff’s coefficient Q10 has been determined to be, resulting in a metabolism at 4 °C of
10% compared to metabolism at 37 °C21,48. Fujita et al determined that the amount of
oxygen that is consumed by a lowered metabolism is a logarithmic function of
temperature48. Using continuous perfusion of the portal vein with temperatures varying
from 5 to 37 °C, they measured a temperature (T)-dependent oxygen consumption VO2
of: VO2 = 0.21 . 100.029Τ  [µmol/min/g-liver]
As the relation between oxygen consumption and temperature is logarithmic, oxygen
consumption decreases with decreasing temperature, but never stops at temperatures of
0-4 °C. At 4 °C, metabolism still requires 0.27 µmol/min/g-liver oxygen, which implies
that a certain oxygen supply during hypothermic liver perfusion is required. This finding
is confirmed by another study of Fujita et al, showing poor viability parameters after
HMP when oxygen was omitted52. On the other hand, oxygen delivery to the organ is
considered as a double-edged sword as it may be beneficial but has the potential to be
injurious as well. In kidney preservation it has been demonstrated that oxygen can result
in generation of toxic reactive oxygen radicals during preservation. Comparative studies
of oxygen-saturated versus oxygen-deprived preservation solutions have shown that a
95% oxygen-saturated perfusate allows good viability, while a total lack of oxygen
results in cellular injury and especially in endothelial cell damage52.
From the data of Fujita et al that oxygen consumption during hypothermic liver
perfusion (VO2) amounts to 0.27 µmol/min/g-liver, it can be determined that, using
Henry's law, the partial oxygen pressure should be48:
where Q is the normalised flow in ml/min/g-liver, H is Henry’s constant, denoting the
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most a-cellular preservation media, Henry's constant for water, 2.95·109 Pa, can be
used causing an estimated error of at most 5%. 
Some reports of successful HMP experiments have identified oxygen to be an
important constituent in the preservation solution (Table 2). As was determined from
Henry’s law, VO2 is directly related with pO2 and flow. Calculating oxygen consumption,
most authors do not meet the oxygen consumption value as determined by Fujita et al
(Table 2). This indicates that results after liver HMP can be improved if a higher pO2
during the entire perfusion period is offered48.
Table 2: Experiments using oxygenated perfusion solutions, pO2 and VO2 values used in liver HMP.
Reference pO2 [kPa] Flow [ml/min/g-liver] VO2 [µmol/min/g-liver]
Fujita et al48 95 3-3.5 5.4
Compagnon et al40 12 0.5 0.11
Southard et al27 13-17 0.14 0.04
Gellert et al22 30-40 0.625 0.041
Pienaar et al20 9 - -
Slapak et al46 21-35 - -
Rossaro et al66 95 0.5 0.89
Summarizing, even in a state of hypothermia, the liver consumes oxygen, implying
that during hypothermic preservation a certain oxygen supply is required. The pO2 in the
perfusate is determined by the flow rate established in relation to oxygen consumption
under hypothermic conditions. 
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Perfusion systems
In continuous liver HMP-research the perfusate, perfusion characteristics and oxygen
supply have been studied in experimental laboratory set-ups. An overview of effective
HMP-related problems including cooling, oxygenation and perfusion dynamics is shown
in Figure 1. Choices are necessary between in-line cooling of the perfusate with a heat
exchanger or cooling of the entire set-up by placing it in a refrigerator or cold room.
Oxygenation is established by using an in-line oxygenator or organ surface oxygenation.
Furthermore, dual pumping via both portal vein (PV) and hepatic artery (HA) or just by
the portal vein alone has been performed. Arterial perfusion is generally achieved by a
peristaltic pump17,19,22,40,47. Peristaltic pumps use the principle of pushing fluid
forward with compression and decompression of tubing. This is usually achieved by
deforming a flexible tube, e.g. in a roller pump. A major advantage of this pumping
principle is that the preservation solution has no direct contact with the pump head,
thus securing sterile conditions. The consequence of the pushing forward principle is
that a peristaltic pump is a flow-driven pump. Any disturbance of the flow due to an
obstruction in the circuit will result in an increasing resistance and produce a high
perfusion pressure. Especially in hypothermic organ perfusion this is a situation which
is not desirable. 
Figure 1: Schematic view of experimental HMP of the liver.
Portal venous perfusion is established by either a peristaltic pump17-20,22,29,40,50,52
or by perfusion using gravity34,47,49. Gravity perfusion is based on the principle that the
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height of an open reservoir above an organ is directly related with the resulting pressure
at which the organ is perfused according to Bernoulli’s law. For example, if a reservoir
containing UW is placed 15 cm above the organ (h), a hydrostatic pressure (p) of
p = ρ·g·h = 11.8 mmHg, with r the specific gravity of UW and g the gravitational
coefficient, will result in a perfusion pressure (P) of P = ρ·g·h-1/2·ρ·ν2, with ν the
velocity of perfusion flow. With this principle a low perfusion pressure can easily be
applied, but as a consequence, this set-up is difficult to use outside the laboratory.
The challenge offered by these experimental set-ups is to design an innovative
hypothermic human liver perfusion system to incorporate these features in a
transportable, portable and easy-to-use system. An easily handled system is not yet
commercially available. For HMP of kidneys now large systems exist, e.g. the Gambro
kidney perfusion machine (Gambro, Stockholm, Sweden)41,53-57 and the RM3 kidney
perfusion machine (Waters Medical Systems, Rochester MN, USA)58,59, as the successor
to the MOX-10060-64 (Figure 2). 
A B
Figure 2: The Gambro (a) and Waters RM3 (b) kidney perfusion machines.
The machines mentioned above basically consist of an organ chamber in which the
organ is placed and a pumping system which directs the preservation solution from a
reservoir to the kidney in a pulsatile manner. In both systems, the preservation solution
is delivered to the organ by means of a positive displacement (tube deforming) pump.
Hypothermia is realised by cooling with ice. Oxygenation is achieved by ambient air in
combination with a membrane oxygenator in the Waters machine or by a certain
overpressure in the organ chamber using a small amount of medical oxygen in the
Gambro machine. 
Although many, predominantly US, studies have reported excellent results with a
lower delayed graft function after kidney transplantation than with CS, HMP has not
become a standard clinical method to perfuse kidneys to bridge the time span between
donor and recipient. Whether this is due to a relatively high transport weight, due to
presumed operating costs or the assumption that handling of machines requires skilled
personnel has remained unclear until today. 
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Outlook on hypothermic machine preservation
The three key players in liver HMP are type of preservation solution, characteristics
of perfusion dynamics and oxygen supply. Reviewing liver HMP experiments, the best
results have been achieved with the University of Wisconsin machine preservation
solution and this solution is clinically most widely used. UW-MP prevents hypothermia-
induced injury, but has also an increased viscosity, compared to 37 °C blood, which
results in a decrease in flow at physiologic pressures. The literature overview reveals that
no clear conclusions can be drawn concerning the optimal perfusion characteristics,
since either only perfusion pressure or perfusion flow is reported. The best estimation
for perfusion of the liver is a physiological approach, i.e. on the arterial side pulsatile
perfusion and on the portal side continuous perfusion is applied. Pressures could be
chosen somewhat lower than physiological pressure to prevent possible endothelial cell
damage under hypothermic conditions, e.g. hepatic artery 60/40 mmHg with 60 BPM and
portal vein 8 mmHg. A third important observation from the literature and additional
calculations suggests that oxygen is mandatory to achieve optimal preservation of the
liver. The minimal amount of partial oxygen pressure [Pa] required is inversely related to
the normalized flow (ml/min/g-liver).
To allow successful clinical application of HMP of the liver the technical
considerations mentioned above have to be taken into account to improve organ
viability after HMP versus CS preservation and reduce post transplant complications. In
addition, however, it is mandatory for the successful use and implementation of HMP of
the liver that the technique is compatible with the standard operating procedures
surgeons are using during organ procurement. The simple static cold storage technique,
the golden standard, should be the basis for the design of a HMP system, and
incorporate equivalent handling, procedures and materials, with the addition of a simple
dual pumping system. The only extra action the surgical team should have to perform is
to connect both the portal as well as the arterial cannula to the pumps. Furthermore,
the entire system should be portable to allow easy transportation and preferably be
disposable, at least in part. For this purpose, according to NIOSH lifting regulations a
weight of 23 kg or less should be the target65. A last important requirement for a liver
HMP system is a stand-alone working period of at least 24 hours, implying a cooling
capacity to maintain hypothermic conditions within the range of 0-4 °C for 24 hours.
Incorporating these design criteria in a transportable system based on existing
standard surgical procedures will successfully implement this technique into every day
clinical practise and substantially contribute to improvement of donor liver quality and
viability and thus shorten the waiting lists for transplantation and hopefully improve
outcome after liver transplantation. In Groningen the department of BioMedical
Engineering and the Surgery Research Laboratory collaborated and designed a new HMP
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apparatus for the liver. The patented design comprises a modular system with mechanics
located in the lid of a polystyrene box. The box is filled with ice and the liver is situated
in a bowl containing UW-MP. UW-MP is re-circulated via disposables: in-line arterial
oxygenator, arterial pump head, portal pump head and arterial- and portal- pressure
sensors. The pump heads connect with two separate pumps via a magnetic lock and are
controlled by software that is downloaded on a palmtop computer. The entire apparatus
is designed to function for 24 hours, stand alone, with cold-storage as backup
(Figure 3).
Figure 3: The Groningen Hypothermic Machine Perfusion set-up for the liver. A. Reservoir;
B. Oxygenator ; C. Oxygen Cylinder; D. Reusable Battery, Control and Motor Pack.
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